Global Market Expansion BAP Pharma has established US operations in New Jersey and Maryland and a presence in Germany, signaling readiness to support sponsors expanding trials into North America and Europe. Their local licenses, warehousing, and global distribution network enable faster site activations and smoother regulatory navigation.

End to End Trial Supply They provide the full clinical trial supply chain: comparator sourcing, packaging and labeling, kit assembly, warehousing, and worldwide distribution. Direct-from-manufacturer sourcing offers cost flexibility, while proven project management and regulatory support reduce delays and compliance risk.

Access & Regulatory Expertise Expertise in Early and Managed Access Programs allows sourcing pre/post approval, orphan, and niche medicines to serve patients globally. Ongoing regulatory affairs, QA, documentation, submissions, real-world data capture, and reimbursement support ease market access and address shortages.

Growth Credibility Award-winning growth and regional recognitions, together with ongoing office expansions, demonstrate scalability and reliability. This track record can help reduce procurement risk and attract sponsors seeking a partner capable of scaling with clinical programs.

Data Driven Ops Technology-enabled operations with global standards, validated label design, and data capture capabilities support transparency, traceability, and regulatory submissions. The combination of communication, data, and global licenses improves efficiency and audit readiness for sponsors.